Avant Technologies Inc. (OTCQB:AVAI) (“Avant” or the “Company”), an emerging technology company developing healthcare solutions, and its Joint Venture partner, Ainnova Tech, Inc. (Ainnova), a leading healthcare technology company focused on revolutionizing early disease detection using artificial intelligence (AI), today announced that Ainnova is refining its patient recruitment strategy for the Company's planned clinical trial […]

(CNSX:INTG.CN),(Boerse Frankfurt – Freiverkehr:ZK9),(OTC US:ITGLF),(Other OTC:ITGLF), CALGARY, Alberta, Aug. 12, 2025 (GLOBE NEWSWIRE) — Integral Metals Corp. (CSE: INTG | OTC: ITGLF | FSE: ZK9) (the “Company” or “Integral”) is pleased to provide an update on its 2025 diamond drilling program at the KAP Project in the Northwest Territories. As previously announced on July 28,

IMC Delivers Strong Profit and Margin Growth Despite Revenue Impact from External Challenges in Q2 2025 IM Cannabis Corp. (the “Company” or “IMC”) (NASDAQ: IMCC), an international medical cannabis company, announced its financial results today for the second quarter ended June 30, 2025. All amounts are reported in Canadian dollars and compared to the quarter

(NasdaqGM:NNOX), Management to host conference call and webcast Tuesday, August 12, 2025 at 8:30 AM ET Company continued to grow Nanox.ARC installed base and is on track to meet its year-end system deployment target PETAH TIKVA, Israel, Aug. 12, 2025 (GLOBE NEWSWIRE) — NANO-X IMAGING LTD (NASDAQ: NNOX) (“Nanox” or the “Company“), an innovative medical

(TSX:CNT), HONG KONG, Aug. 12, 2025 (GLOBE NEWSWIRE) — Century Global Commodities Corporation (“Century” or the “Company“) (TSX: CNT) is pleased to announce that it has filed its condensed consolidated interim financial statements for the first fiscal quarter ended June 30, 2025 and the related management discussion and analysis (“MD&A”). Copies of these documents are

(NYSE:VPG), MALVERN, Pa., Aug. 12, 2025 (GLOBE NEWSWIRE) — Vishay Precision Group, Inc. (NYSE: VPG), a leader in precision measurement and sensing technologies, will present at the following investor conferences: 16th Annual Midwest IDEAS Conference on Wednesday, August 27, 2025, at the InterContinental Chicago Magnificent Mile, Chicago, IL. The company's presentation is scheduled to begin

(TSX-V:NURS),(Boerse Frankfurt – Freiverkehr:SO6),(OTC US:HYDTF),(Other OTC:HYDTF),(Boerse Frankfurt – Freiverkehr:SO6.F),(CNSX:VST.CN),(Other OTC:VSQTF),(Frankfurt:6F6.F), VANCOUVER, British Columbia, Aug. 12, 2025 (GLOBE NEWSWIRE) — Hydreight Technologies Inc. (TSXV: NURS, OTC: HYDTF, FSE: SO6) (“Hydreight” or the “Company”), a leader in nationwide digital healthcare solutions, is pleased to provide a corporate update highlighting record-breaking VSDHOne order growth, the strategic benefits of

(PinkSheets:EHVVF),(OTC US:AIBT),(OtherOTC:AIBT),(Pinksheets:EHVVF), MIAMI, Aug. 12, 2025 (GLOBE NEWSWIRE) — AIBotics, Inc. (“AIBotics” or the “Company”) (OTC: AIBT), a subsidiary of Ehave (OTC: EHVVF) that develops and manages AI- and robotics-enhanced technologies, today announced an outline of its corporate progress, technology development, and a strategic roadmap for agentic AI integration in the last half of 2025.

SALT LAKE CITY, Utah, Aug. 12, 2025 (GLOBE NEWSWIRE) — Hirevue, the global leader in skills-based hiring, today announced the launch of Hirevue Talent Engagement, an AI-powered hiring agent designed to help talent acquisition teams conquer the challenge of finding the right candidates with the right skills at speed and scale, but without sacrificing the

(NASDAQ:GRCE), Submission of New Drug Application (NDA) to U.S. Food and Drug Administration (FDA) for GTx-104 Seeking Approval of GTx-104 in the Treatment of Patients with aneurysmal Subarachnoid Hemorrhage (aSAH) NDA Supported by Data from Phase 3 STRIVE-ON Safety Trial, which Met Primary Endpoint and Provided Evidence of Clinical Benefit Compared to Orally Administered Nimodipine